Data for drug reviews

The Oregon Prescription Drug Price Transparency program provides the board with prescription drug data submitted under ORS 646A.689 (2) and (6), and ORS 743.025. Information also comes from the Oregon Health Authority’s All Payer All Claims (APAC) reporting program and a DCBS data call from Oregon insurance carriers. Information is aggregated and de-identified. PDAB strictly maintains the confidentiality of any information collected, used or relied upon for the review that is protected trade secret, confidential, or proprietary information, as defined in ORS 192.345.